Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Jaguar Health
AddedFeb 19, 2024
UpdatedJun 18, 2026
Jaguar Health

Jaguar Health

Public

Jaguar Health, Inc.: A global pharmaceutical firm specializing in plant-based gastrointestinal medicines for humans and animals.

HQ
San Francisco, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Jaguar Health, Inc., founded with a mission to address urgent global health needs, specializes in the discovery, development, and commercialization of plant-based gastrointestinal medicines for both humans and animals. The company offers a range of prescription and non-prescription products aimed at treating various gastrointestinal conditions. Jaguar Health targets the global human and animal health markets, leveraging natural products to provide innovative healthcare solutions.

Notable figures affiliated with Jaguar Health include its leadership team and key investors who have supported its growth. The company has achieved significant milestones, such as the successful development and commercialization of its flagship products. Jaguar Health's impact is marked by its commitment to providing effective, plant-based treatments, contributing to advancements in both human and animal healthcare on a global scale.

Jaguar Health - Quick Facts

When was Jaguar Health founded?

Jaguar Health was founded in 2013.

Where is Jaguar Health's headquarters located?

Jaguar Health's headquarters is located in San Francisco, CA, US.

When was Jaguar Health's last funding round?

Jaguar Health's most recent funding round was for $10.8M (USD) in April 2021.

How much has Jaguar Health raised to-date?

As of Apr 29, 2021, Jaguar Health has raised a total of $59.4M (USD).

How many employees does Jaguar Health have?

Jaguar Health has 52 employees as of Feb 6, 2024.

Jaguar Health - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Pharmaceuticals
Tags
  • Biotech
Unique IDs
  • ein: 000000000
  • secCik: 0001585608
  • ticker: JAGX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 812910Pet Care (except Veterinary) Services
  • 620000Health Care and Social Assistance
  • 810000Other Services (except Public Administration)
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 812000Personal and Laundry Services
  • 812900Other Personal Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 700Agricultural Services
  • 750Animal Services, Except Veterinary
  • 752Animal Specialty Services, Except Veterinary
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 9609Other personal service activities n.e.c.